|
Description:
|
|
Cannabidiol (CBD), a chemical compound from the Cannabid sativa plant, may be less potent than its stony cannabis cousin THC, however CBD might be the far riskier relative. Nearly a dozen major CBD-related class action lawsuits, as well as a handful of legal and regulatory actions against some CBD companies, are pending. All of this bears watching by those in the sector who manage and deal in risk.
The post CBD, THC’s Mild-Mannered Kin, is a Risk Worth Watching appeared first on Insurance Journal TV. |